New xenograft model of sporadic inclusion body myositis shows no role of T-cell depletion Feb. 7, 2022
Brickell licenses rights to Carna's STING antagonists for autoimmune and inflammatory diseases Feb. 3, 2022
Targeting PPARalpha-ACOT12 axis as a potential new therapeutic strategy for osteoarthritis Feb. 3, 2022
RSS